A Meta-analysis of Drug Eluting Stents Versus Bare Metal Stents in Saphenous Vein Graft Disease

Saphenous Vein Graft Disease Clinical Trial

Official title:

Drug Eluting Stents Versus Bare Metal Stents in Saphenous Vein Graft Disease: Insights From a Meta-analysis

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01036048
• Other study ID #: N28LBCF80-07
• Status: Completed
• Phase: N/A
• First received: December 7, 2009
• Last updated: December 18, 2009
• Start date: May 2009
• Est. completion date: December 2009

Study information

• Verified date: December 2009
• Source: Catholic University of the Sacred Heart
• Contact: n/a
• Is FDA regulated: No
• Health authority: Italy: Ethics Committee
• Study type: Observational

Clinical Trial Summary

A meta-analysis to compare outcomes of drug eluting stents (DES) versus bare metal stent (BMS) in saphenous vein graft (SVG) disease.

Description:

To compare outcomes (death, myocardial infarction, target vessel revascularization) of drug eluting stent versus bare metal stent in saphenous vein graft disease.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 5806
• Est. completion date: December 2009
• Est. primary completion date: December 2009
• Accepts healthy volunteers: No
• Gender: Both
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• CABG disease

• randomized studies

• not randomized studies

Exclusion Criteria:

• studies reporting composite and not single endpoints, duplicate reporting

Study Design

Time Perspective: Retrospective

Related Conditions & MeSH terms

• Saphenous Vein Graft Disease

Intervention

Device:
• drug eluting stent
pts with cabg disease treated with drug eluting stent
• bare metal stent
pts with cabg disease treated with bare metal stent

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Catholic University of the Sacred Heart

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	death		years depending from studies retrieved	No
Secondary	myocardial infarction		years depending from study retrieved	No
Secondary	target vessel revascularization		years depending from study retrieved	No